Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inotropes in the beta-blocker era.

B D Lowes1, M A Simon, T O Tsvetkova

  • 1Division of Cardiology, University of Colorado Health Sciences Center, Denver 80262, USA.

Clinical Cardiology
|February 7, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.

Alimentary pharmacology & therapeutics·2024
Same author

Feasibility of a Composite Measure of Pulmonary Vascular Impedance and Application to Patients with Chronic RV Failure Post LVAD Implant.

Cardiovascular engineering and technology·2023
Same author

Patients' preferences for treatment with the new direct acting antiviral therapies for chronic hepatitis C virus infection.

Revista espanola de sanidad penitenciaria·2021
Same author

Heat rectification with a minimal model of two harmonic oscillators.

Physical review. E·2021
Same author

Unusual presentation of intussusception: Gallstone ileus.

Radiography (London, England : 1995)·2020
Same author

Asymmetric heat transport in ion crystals.

Physical review. E·2019
Same journal

In-Hospital Cardiac Arrest Detection Performance Analysis and Comparison on Effective Feature Selection.

Clinical cardiology·2026
Same journal

Interpreting the Association Between Diuretic Intensity Score and Mortality: The Potential Roles of Diuretic Responsiveness and Mineralocorticoid Receptor Antagonist Therapy.

Clinical cardiology·2026
Same journal

Heart Failure With Preserved Ejection Fraction-Like Phenotype in Coronary Artery Disease and Obstructive Sleep Apnea: Insights From the RICCADSA Cohort.

Clinical cardiology·2026
Same journal

Ethanol Infusion Into the Vein of Marshall for Atrial Fibrillation: Clinical Efficacy and Technical Limitations.

Clinical cardiology·2026
Same journal

Methodological Considerations Regarding Diuretic Intensity Score and Mortality in Hospitalized Heart Failure Patients.

Clinical cardiology·2026
Same journal

Inpatient Outcomes and Complications After Left Atrial Appendage Occlusion in Rural Versus Urban Hospitals in the United States.

Clinical cardiology·2026
See all related articles

Phosphodiesterase inhibitors (PDEIs) offer sustained hemodynamic support during beta-blocker treatment for chronic heart failure (CHF). This combination therapy shows promise by enhancing efficacy and reducing adverse effects in heart failure patients.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Beta-adrenergic blocking agents are standard for chronic heart failure (CHF).
  • Some patients do not respond to beta-blockers or may deteriorate.
  • Acute decompensation may necessitate positive inotropic agents.

Purpose of the Study:

  • To evaluate the efficacy of phosphodiesterase inhibitors (PDEIs) in patients on beta-blocker therapy for CHF.
  • To explore the additive benefits and subtractive adverse effects of combining PDEIs with beta-blockers.
  • To assess the potential of PDEIs to improve beta-blocker initiation tolerability.

Main Methods:

  • Investigated the hemodynamic effects of PDEIs in the presence of beta blockade.
  • Examined the mechanism of PDEI action beyond the beta-adrenergic receptor.

Related Experiment Videos

  • Assessed the long-term effects of combined PDEI and beta-blocker administration in CHF models.

    • Main Results:

    • PDEIs retain full hemodynamic effects despite beta blockade.
    • Beta blockade reverses detrimental receptor desensitization, enhancing PDEI response.
    • Combined therapy demonstrated additive efficacy and subtractive adverse effects.
    • PDEI administration improved tolerability of beta-blocker initiation.

    Conclusions:

    • The combination of PDEIs and beta-blockers shows promising clinical results for CHF.
    • This combination preserves key beta-blocker effects like decreased heart rate and increased ejection fraction.
    • Large-scale placebo-controlled studies are needed to confirm these findings.